Hiscox share price falls as Covid-19 losses rise to $232mn

Hiscox saw its share price fall almost five percent as the market opened today after it raised its Covid-19 loss estimate to $232mn and said its combined ratio had deteriorated 15.8 percentage points in H1 2020.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com